<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05031936</url>
  </required_header>
  <id_info>
    <org_study_id>2021-07-014</org_study_id>
    <nct_id>NCT05031936</nct_id>
  </id_info>
  <brief_title>: Intravascular Injection Rates During Cervical Medial Branch Block</brief_title>
  <official_title>Comparison of Intravascular Injection Rates During Cervical and Lumbar Medial Branch Block Using Touhy or Quincke Type Needle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Keimyung University Dongsan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Keimyung University Dongsan Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare using Toughy needle has an advantage of reducing&#xD;
      intravascular injection rates during cervical medial branch block.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In previous reports, the use of Toughy needle was thought to reduce the incidence of&#xD;
      intravascular injection as low as 2.9% during lumbar transforaminal injection.&#xD;
&#xD;
      Blunt needles with a pencil point tip, such as Whitacre needles, are not as sharp at their&#xD;
      tip as are Quincke needles, which have bevels. Toughy or blunt needles may therefore be less&#xD;
      likely to penetrate a vessel during a procedure. Hence, we postulated the incidence of&#xD;
      intravenous uptake would be significantly lower using a Toughy needle than using a Quincke&#xD;
      needle for lumbar medial branch block. To confirm the intravascular injection rates, we used&#xD;
      the real time fluoroscopy after injection of contrast medium.&#xD;
&#xD;
      The goal of this study was to compare the incidence of intravascular injection rate betweeen&#xD;
      Toughy and Quincke needles using real time fluoroscopy during cervical medial branch block&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2021</start_date>
  <completion_date type="Anticipated">April 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of intravascular injection</measure>
    <time_frame>1 minute after finishing cervical medial branch block</time_frame>
    <description>incidence of intravascular injection during cervical medial branch block</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time required to complete cervical medial branch block</measure>
    <time_frame>Baseline, 1 second after the completion of cervical medial branch block</time_frame>
    <description>time required to complete cervical medial branch block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>radiation amout to complete cervical medial branch block</measure>
    <time_frame>Baseline, 1 second after the completion of cervical medial branch block</time_frame>
    <description>radiation amout to complete cervical medial branch block</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Vascular Complications</condition>
  <arm_group>
    <arm_group_label>Touhy needle group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>cervical medial branch block using touhy needle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Quincke needle group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>cervical medial branch block using quincke needle</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cervical spinal injection with 0.2% ropivacaine</intervention_name>
    <description>spinal injections performed in cervical pillar area to relieve chronic neck pain</description>
    <arm_group_label>Quincke needle group</arm_group_label>
    <arm_group_label>Touhy needle group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  facet joint arthropathy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergy to local anesthetics or contrast medium&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  spine deformity&#xD;
&#xD;
          -  neurologic abnormality&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ji Hee Hong</last_name>
    <role>Principal Investigator</role>
    <affiliation>Keimyung University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ji Hee Hong</last_name>
    <phone>01046794343</phone>
    <email>swon13@daum.net</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ji Seob Kim</last_name>
    <phone>01027487480</phone>
    <email>painfree0309@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hong ji HEE</name>
      <address>
        <city>Daegu</city>
        <zip>42601</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J Hee Hong</last_name>
      <phone>82-53-258-7767</phone>
      <email>swon13@daum.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 19, 2021</study_first_submitted>
  <study_first_submitted_qc>August 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 2, 2021</study_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Keimyung University Dongsan Medical Center</investigator_affiliation>
    <investigator_full_name>Ji Hee Hong</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>intravascular injection</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

